Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT2: Transperineal vs. Transrectal MRI-targeted Prostate Biopsy
NCT04815876Completed
- Sponsor
- Weill Cornell Medicine
- Start
- Jun 2021
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Weill Cornell Medicine. Primary endpoint: Number of Participants With Infection/Adverse Events. Started Jun 2021; status: completed.
Beyond the preview
Go deeper on NCT04815876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04815876.